Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04419857 · ClinicalTrials.gov registry record · NA
A Trial to Determine Weight Gain Benefits of Caloric Supplementation for NAS Infants
A NA study of Neonatal Abstinence Syndrome, sponsored by Yale University.
- Active
- Registry status
- NA
- Development phase
- 39
- Enrollment target
- 1
- Study location
NCT04419857 is a NA study of Neonatal Abstinence Syndrome that is active but no longer recruiting, run by Yale University. The registered enrollment target is 39 participants, below the 64-participant average among 17 other Neonatal Abstinence Syndrome trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04419857, a NA study of Neonatal Abstinence Syndrome, is active but no longer recruiting, sponsored by Yale University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
- 1
- Study location
Study Summary
A randomized clinical study in NAS infants managed via the Eat, Sleep, Console (ESC) approach comparing early weight loss on a standard-caloric density versus high-caloric density feeding regimen.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT High-calorie formula
Study Locations (1)
Connecticut
- Yale New Haven Hospital - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2020-12-04 |
| Est. Completion | 2026-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04419857
The ClinicalTrials.gov registry entry for NCT04419857 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 64-participant average among 17 other Neonatal Abstinence Syndrome trials with a reported enrollment target (39% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Neonatal Abstinence Syndrome appearing as the primary indexed condition, and to 1 intervention - of which High-calorie formula is the first listed.
NCT04419857 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT04419857 about?
NCT04419857 is a clinical study titled "A Trial to Determine Weight Gain Benefits of Caloric Supplementation for NAS Infants". A randomized clinical study in NAS infants managed via the Eat, Sleep, Console (ESC) approach comparing early weight loss on a standard-caloric density versus high-caloric density feeding regimen.
What is the current status of trial NCT04419857?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 39 participants. The study started on 2020-12-04. Estimated completion is 2026-05.
What conditions does trial NCT04419857 study?
This clinical trial studies the following conditions: Neonatal Abstinence Syndrome.
What interventions are being tested in trial NCT04419857?
The interventions under investigation include: High-calorie formula (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04419857?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04419857 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neonatal Abstinence Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
An Intervention Mapping Approach to Closing the Gap in Maternal OUD and Infant NAS Care (SUPPORT)
RECRUITING · NA
-
Effective Caregiving for Neonatal Abstinence Syndrome: Testing an Instructional Mobile Technology Platform for High-Risk Pregnant Women
ACTIVE NOT RECRUITING · NA
-
Neurostimulation to Improve NOWS Outcomes
ACTIVE NOT RECRUITING · NA
-
Role of Low Lactose Infant Formula In The Management of Neonatal Abstinence Syndrome
COMPLETED · NA
-
MicroRNA Biomarkers for Neonatal Opioid Withdrawal Syndrome
RECRUITING
-
Treatment of Neonatal Abstinence Syndrome With Clonidine Versus Morphine as Primary Therapy
ACTIVE NOT RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.